MedTrace Logo

Expression of EPK in Recurrent Miscarriage

NCT02694367 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 39

Last updated 2016-02-29

No results posted yet for this study

Summary

The present study is based on hypotheses that some as yet unknown genetic factors may result in recurrent miscarriage (RM). Consequently, the main aim of this study was to gain new information about the underlying genetic causes of RM in the Egyptian population and to investigate the expression of ERK and p-ERK protein in human placenta and their corresponding tissue, to assess the significance of MAPK signal pathway in progression of recurrent miscarriage and PI3K-Akt Pathway.

Conditions

  • Recurrent Miscarriage

Interventions

OTHER

Investigate the MAP kinase signaling pathways through ERK and p-ERK proteins

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-12-31
Completion
2016-01-31

Countries

  • Egypt

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02694367 on ClinicalTrials.gov